Year |
Citation |
Score |
2023 |
Essmat N, Karádi DÁ, Zádor F, Király K, Fürst S, Al-Khrasani M. Insights into the Current and Possible Future Use of Opioid Antagonists in Relation to Opioid-Induced Constipation and Dysbiosis. Molecules (Basel, Switzerland). 28. PMID 38067494 DOI: 10.3390/molecules28237766 |
0.348 |
|
2023 |
Karádi DÁ, Galambos AR, Lakatos PP, Apenberg J, Abbood SK, Balogh M, Király K, Riba P, Essmat N, Szűcs E, Benyhe S, Varga ZV, Szökő É, Tábi T, Al-Khrasani M. Telmisartan Is a Promising Agent for Managing Neuropathic Pain and Delaying Opioid Analgesic Tolerance in Rats. International Journal of Molecular Sciences. 24. PMID 37175678 DOI: 10.3390/ijms24097970 |
0.395 |
|
2023 |
Kozsurek M, Király K, Gyimesi K, Lukácsi E, Fekete C, Gereben B, Mohácsik P, Helyes Z, Bölcskei K, Tékus V, Pap K, Szűcs E, Benyhe S, Imre T, Szabó P, et al. Unique, Specific CART Receptor-Independent Regulatory Mechanism of CART(55-102) Peptide in Spinal Nociceptive Transmission and Its Relation to Dipeptidyl-Peptidase 4 (DDP4). International Journal of Molecular Sciences. 24. PMID 36674439 DOI: 10.3390/ijms24020918 |
0.341 |
|
2020 |
Fürst S, Zádori ZS, Zádor F, Király K, Balogh M, László SB, Hutka B, Mohammadzadeh A, Calabrese C, Galambos AR, Riba P, Romualdi P, Benyhe S, Timár J, Schmidhammer H, et al. On the Role of Peripheral Sensory and Gut Mu Opioid Receptors: Peripheral Analgesia and Tolerance. Molecules (Basel, Switzerland). 25. PMID 32466522 DOI: 10.3390/Molecules25112473 |
0.437 |
|
2020 |
Zádor F, Mohammadzadeh A, Balogh M, Zádori ZS, Király K, Barsi S, Galambos AR, László SB, Hutka B, Váradi A, Hosztafi S, Riba P, Benyhe S, Fürst S, Al-Khrasani M. Comparisons of In Vivo and In Vitro Opioid Effects of Newly Synthesized 14-Methoxycodeine-6--sulfate and Codeine-6--sulfate. Molecules (Basel, Switzerland). 25. PMID 32192229 DOI: 10.3390/Molecules25061370 |
0.505 |
|
2019 |
Al-Khrasani M, Mohammadzadeh A, Balogh M, Király K, Barsi S, Hajnal B, Köles L, Zádori ZS, Harsing LG. Glycine transporter inhibitors: A new avenue for managing neuropathic pain. Brain Research Bulletin. 152: 143-158. PMID 31302238 DOI: 10.1016/J.Brainresbull.2019.07.008 |
0.317 |
|
2019 |
Balogh M, Zádor F, Zádori ZS, Shaqura M, Király K, Mohammadzadeh A, Varga B, Lázár B, Mousa SA, Hosztafi S, Riba P, Benyhe S, Gyires K, Schäfer M, Fürst S, et al. Efficacy-Based Perspective to Overcome Reduced Opioid Analgesia of Advanced Painful Diabetic Neuropathy in Rats. Frontiers in Pharmacology. 10: 347. PMID 31024314 DOI: 10.3389/Fphar.2019.00347 |
0.51 |
|
2019 |
Balogh M, Varga BK, Karádi DÁ, Riba P, Puskár Z, Kozsurek M, Al-Khrasani M, Király K. Similarity and dissimilarity in antinociceptive effects of dipeptidyl-peptidase 4 inhibitors, Diprotin A and vildagliptin in rat inflammatory pain models following spinal administration. Brain Research Bulletin. PMID 30738866 DOI: 10.1016/J.Brainresbull.2019.02.001 |
0.45 |
|
2018 |
Király K, Kozsurek M, Lukácsi E, Barta B, Alpár A, Balázsa T, Fekete C, Szabon J, Helyes Z, Bölcskei K, Tékus V, Tóth ZE, Pap K, Gerber G, Puskár Z. Glial cell type-specific changes in spinal dipeptidyl peptidase 4 expression and effects of its inhibitors in inflammatory and neuropatic pain. Scientific Reports. 8: 3490. PMID 29472575 DOI: 10.1038/S41598-018-21799-8 |
0.468 |
|
2017 |
Zádor F, Balogh M, Váradi A, Zádori ZS, Király K, Szűcs E, Varga B, Lázár B, Hosztafi S, Riba P, Benyhe S, Fürst S, Al-Khrasani M. 14-O-Methylmorphine: A Novel Selective Mu-Opioid Receptor Agonist with High Efficacy and Affinity. European Journal of Pharmacology. PMID 28864212 DOI: 10.1016/J.Ejphar.2017.08.034 |
0.468 |
|
2017 |
Zádor F, Király K, Váradi A, Balogh M, Fehér Á, Kocsis D, Erdei AI, Lackó E, Zádori ZS, Hosztafi S, Noszál B, Riba P, Benyhe S, Fürst S, Al-Khrasani M. New opioid receptor antagonist: naltrexone-14-O-sulfate synthesis and pharmacology. European Journal of Pharmacology. PMID 28502630 DOI: 10.1016/J.Ejphar.2017.05.024 |
0.454 |
|
2016 |
Lacko E, Riba P, Giricz Z, Varadi A, Cornic L, Balogh M, Kiraly K, Cseko K, Mousa SA, Hosztafi S, Schafer M, Zadori ZS, Helyes Z, Ferdinandy P, Furst S, et al. New morphine analogues produce peripheral antinociception within a certain dose range of their systemic administration. The Journal of Pharmacology and Experimental Therapeutics. PMID 27435180 DOI: 10.1124/Jpet.116.233551 |
0.442 |
|
2015 |
Kiraly K, Caputi FF, Hanuska A, Kató E, Balogh M, Köles L, Palmisano M, Riba P, Hosztafi S, Romualdi P, Candeletti S, Ferdinandy P, Fürst S, Al-Khrasani M. A new potent analgesic agent with reduced liability to produce morphine tolerance. Brain Research Bulletin. 117: 32-8. PMID 26235542 DOI: 10.1016/J.Brainresbull.2015.07.005 |
0.704 |
|
2014 |
Horváth G, Gölöncsér F, Csölle C, Király K, Andó RD, Baranyi M, Koványi B, Máté Z, Hoffmann K, Algaier I, Baqi Y, Müller CE, Von Kügelgen I, Sperlágh B. Central P2Y12 receptor blockade alleviates inflammatory and neuropathic pain and cytokine production in rodents. Neurobiology of Disease. 70: 162-78. PMID 24971933 DOI: 10.1016/J.Nbd.2014.06.011 |
0.412 |
|
2013 |
Sobor M, Timár J, Riba P, Király KP, Al-Khrasani M, Gyarmati Z, Fürst Z. [Behavioural studies during the gestational-lactation period in morphine treated rats]. Neuropsychopharmacologia Hungarica : a Magyar PszichofarmakolóGiai EgyesüLet Lapja = Official Journal of the Hungarian Association of Psychopharmacology. 15: 239-51. PMID 24380965 |
0.372 |
|
2013 |
Szentirmay AK, Király KP, Lenkey N, Lackó E, Al-Khrasani M, Friedmann T, Timár J, Gyarmati S, Tóth G, Fürst S, Riba P. Spinal interaction between the highly selective μ agonist DAMGO and several δ opioid receptor ligands in naive and morphine-tolerant mice. Brain Research Bulletin. 90: 66-71. PMID 22995282 DOI: 10.1016/J.Brainresbull.2012.09.006 |
0.456 |
|
2012 |
Al-Khrasani M, Lackó E, Riba P, Király K, Sobor M, Timár J, Mousa S, Schäfer M, Fürst S. The central versus peripheral antinociceptive effects of μ-opioid receptor agonists in the new model of rat visceral pain Brain Research Bulletin. 87: 238-243. PMID 22079588 DOI: 10.1016/J.Brainresbull.2011.10.018 |
0.483 |
|
2011 |
Spetea M, Windisch P, Guo Y, Bileviciute-Ljungar I, Schütz J, Asim MF, Berzetei-Gurske IP, Riba P, Kiraly K, Fürst S, Al-Khrasani M, Schmidhammer H. Synthesis and pharmacological activities of 6-glycine substituted 14-phenylpropoxymorphinans, a novel class of opioids with high opioid receptor affinities and antinociceptive potencies. Journal of Medicinal Chemistry. 54: 980-8. PMID 21235243 DOI: 10.1021/Jm101211P |
0.475 |
|
2011 |
Király K, Lambeir AM, Szalai J, Szentirmay A, Luyten W, Barna I, Puskár Z, Kozsurek M, Rónai AZ. The dipeptidyl peptidase IV (CD26, EC 3.4.14.5) inhibitor vildagliptin is a potent antihyperalgesic in rats by promoting endomorphin-2 generation in the spinal cord. European Journal of Pharmacology. 650: 195-9. PMID 20940010 DOI: 10.1016/J.Ejphar.2010.09.060 |
0.722 |
|
2011 |
Sobor M, Timár J, Riba P, Friedmann T, Király KP, Gyarmati S, Al-Khrasani M, Fürst S. Effects of opioid agonist and antagonist in dams exposed to morphine during the perinatal period. Brain Research Bulletin. 84: 53-60. PMID 20934489 DOI: 10.1016/J.Brainresbull.2010.10.001 |
0.431 |
|
2011 |
Szentirmay A, Király K, Puskár Z, Kozsurek M, Rónai AZ. The antihyperalgesic and acute antinociceptive effects of intrathecally injected DAMGO, endomorphin 2 and the endomorphin 2 biosynthesis inducers ILE-PRO-ILE and vildagliptin in rats Pharmacological Reports. 63: 242-242. DOI: 10.1016/S1734-1140(11)70464-9 |
0.685 |
|
2011 |
Szentirmay AK, Király KP, Al-Khrasani M, Lackó E, Friedmann T, Gyarmati S, Timár J, Fürst S, Riba P. Dose-dependent potentiation by the δ antagonist cha-TIPPpsi on the spinal antinociceptive effect of the μ agonist DAMGO in opioid-naive rats Pharmacological Reports. 63: 241-242. DOI: 10.1016/S1734-1140(11)70463-7 |
0.54 |
|
2011 |
Király K, Kozsurek M, Puskár Z, Szentirmay A, Fekete C, Rónai AZ. The possible role of endomorphin 2 biosynthesis and CART peptide in the nociceptive information processing in rat spinal dorsal horn: pharmacology and immunohistochemistry Pharmacological Reports. 63: 241. DOI: 10.1016/S1734-1140(11)70462-5 |
0.67 |
|
2010 |
Sobor M, Timár J, Riba P, Király KP, Gyarmati S, Al-Khrasani M, Fürst S. Does the effect of morphine challenge change on maternal behaviour of dams chronically treated with morphine during gestation and further on during lactation? Pharmacology, Biochemistry, and Behavior. 95: 367-74. PMID 20193708 DOI: 10.1016/J.Pbb.2010.02.015 |
0.423 |
|
2010 |
Timár J, Sobor M, Király KP, Gyarmati S, Riba P, Al-Khrasani M, Fürst S. Peri, pre and postnatal morphine exposure: exposure-induced effects and sex differences in the behavioural consequences in rat offspring. Behavioural Pharmacology. 21: 58-68. PMID 20038835 DOI: 10.1097/Fbp.0B013E3283359F39 |
0.35 |
|
2010 |
Riba P, Friedmann T, Király KP, Al-Khrasani M, Sobor M, Asim MF, Spetea M, Schmidhammer H, Furst S. Novel approach to demonstrate high efficacy of mu opioids in the rat vas deferens: a simple model of predictive value. Brain Research Bulletin. 81: 178-84. PMID 19800397 DOI: 10.1016/J.Brainresbull.2009.09.011 |
0.488 |
|
2009 |
Király K, Szalay B, Szalai J, Barna I, Gyires K, Verbeken M, Rónai AZ. Intrathecally injected Ile-Pro-Ile, an inhibitor of membrane ectoenzyme dipeptidyl peptidase IV, is antihyperalgesic in rats by switching the enzyme from hydrolase to synthase functional mode to generate endomorphin 2. European Journal of Pharmacology. 620: 21-6. PMID 19695241 DOI: 10.1016/J.Ejphar.2009.08.018 |
0.726 |
|
2009 |
Rónai AZ, Király K, Szebeni A, Szemenyei E, Prohászka Z, Darula Z, Tóth G, Till I, Szalay B, Kató E, Barna I. Immunoreactive endomorphin 2 is generated extracellularly in rat isolated L4,5 dorsal root ganglia by DPP-IV. Regulatory Peptides. 157: 1-2. PMID 19540879 DOI: 10.1016/J.Regpep.2009.06.006 |
0.631 |
|
2009 |
Riba P, Király KP, Friedmann T, Al-Khrasani M, Sobor M, Fürst S. Spinal interaction between μ and δ opioid receptors in naive and morphine-tolerant rats Bmc Pharmacology. 9: 1-2. DOI: 10.1186/1471-2210-9-S2-A48 |
0.498 |
|
2008 |
Zádori ZS, Shujaa N, Köles L, Király KP, Tekes K, Gyires K. Nocistatin and nociceptin given centrally induce opioid-mediated gastric mucosal protection. Peptides. 29: 2257-65. PMID 18930088 DOI: 10.1016/J.Peptides.2008.09.012 |
0.399 |
|
2007 |
Al-Khrasani M, Spetea M, Friedmann T, Riba P, Király K, Schmidhammer H, Furst S. DAMGO and 6beta-glycine substituted 14-O-methyloxymorphone but not morphine show peripheral, preemptive antinociception after systemic administration in a mouse visceral pain model and high intrinsic efficacy in the isolated rat vas deferens. Brain Research Bulletin. 74: 369-75. PMID 17845912 DOI: 10.1016/J.Brainresbull.2007.07.008 |
0.5 |
|
2007 |
Al-Khrasani M, Spetea M, Friedmann T, Riba P, Király KP, Schmidhammer H, Fürst S. The peripheral antinociceptive effect of DAMGO and 6β-glycine-substituted 14-O-methyloxymorphone (HS-731) after systemic administration in a mouse visceral pain model Bmc Pharmacology. 7: 1-1. DOI: 10.1186/1471-2210-7-S2-A50 |
0.474 |
|
2007 |
Király KP, Riba P, Friedmann T, Al-Khrasani M, Schmidhammer H, Fürst S. 14-Methoxy-metopon: a highly potent μ opioid agonist on rat vas deferens Bmc Pharmacology. 7: 1-1. DOI: 10.1186/1471-2210-7-S2-A45 |
0.528 |
|
2006 |
Király KP, Riba P, D'Addario C, Di Benedetto M, Landuzzi D, Candeletti S, Romualdi P, Furst S. Alterations in prodynorphin gene expression and dynorphin levels in different brain regions after chronic administration of 14-methoxymetopon and oxycodone-6-oxime. Brain Research Bulletin. 70: 233-9. PMID 16861108 DOI: 10.1016/J.Brainresbull.2006.05.005 |
0.45 |
|
Show low-probability matches. |